Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $61.5 Million - $73.7 Million
-1,000,000 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $57.7 Million - $65.4 Million
1,000,000 New
1,000,000 $62 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $172 Million - $225 Million
-3,500,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $53.5 Million - $63.4 Million
1,250,000 Added 55.56%
3,500,000 $177 Million
Q2 2019

Aug 09, 2019

BUY
$44.62 - $49.34 $71.4 Million - $78.9 Million
1,600,000 Added 246.15%
2,250,000 $102 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $4.51 Million - $5.38 Million
100,000 Added 18.18%
650,000 $31 Million
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $9.75 Million - $12.6 Million
-200,000 Reduced 26.67%
550,000 $28.6 Million
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $27.6 Million - $31.1 Million
-500,000 Reduced 40.0%
750,000 $46.6 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $17.7 Million - $22 Million
350,000 Added 38.89%
1,250,000 $69.2 Million
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $15 Million - $16.3 Million
250,000 Added 38.46%
900,000 $55.2 Million
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $35.9 Million - $41.4 Million
650,000
650,000 $41.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.